Literature DB >> 982358

Formation of prostagland in D2 during endoperoxide-induced platelet aggregation.

J B Smith, C M Ingerman, M J Silver.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 982358     DOI： 10.1016/0049-3848(76)90141-9

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  4 in total

1.  Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.

Authors:  R J Haslam; M M Davidson; J V Desjardins
Journal:  Biochem J       Date:  1978-10-15       Impact factor: 3.857

Review 2.  The prostanoids in hemostasis and thrombosis: a review.

Authors:  J B Smith
Journal:  Am J Pathol       Date:  1980-06       Impact factor: 4.307

3.  Inhibition of platelet-activating-factor-induced human platelet activation by prostaglandin D2. Differential sensitivity of platelet transduction processes and functional responses to inhibition by cyclic AMP.

Authors:  M Bushfield; A McNicol; D E MacIntyre
Journal:  Biochem J       Date:  1985-11-15       Impact factor: 3.857

4.  The effect of CV-4151, a selective inhibitor of thromboxane synthetase, on prostanoid formation and platelet aggregation in humans.

Authors:  T Kuzuya; Y Kimura; S Hoshida; K Kodama; N Nakamura; Y Hamanaka; A Kitabatake; T Kamada; M Tada
Journal:  Cardiovasc Drugs Ther       Date:  1988-12       Impact factor: 3.727
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.